img

Global Pet Biopharmaceuticals Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Pet Biopharmaceuticals Market Insights, Forecast to 2034

Market Analysis and InsightsGlobal Pet Biopharmaceuticals Market
The global Pet Biopharmaceuticals market is projected to grow from US$ million in 2024 to US$ million by 2034, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Pet Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The China market for Pet Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The Europe market for Pet Biopharmaceuticals is estimated to increase from $ million in 2024 to reach $ million by 2034, at a CAGR of % during the forecast period of 2024 through 2034.
The global key companies of Pet Biopharmaceuticals include Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc. in 2022, the global top five players had a share approximately % in terms of revenue.
Report Includes
This report presents an overview of global market for Pet Biopharmaceuticals market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2024, and projections of CAGR through 2034.
This report researches the key producers of Pet Biopharmaceuticals, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Pet Biopharmaceuticals, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Pet Biopharmaceuticals revenue, market share and industry ranking of main companies, data from 2018 to 2024. Identification of the major stakeholders in the global Pet Biopharmaceuticals market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2034. Evaluation and forecast the market size for Pet Biopharmaceuticals revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Zoetis, Boehringer Ingelheim, Merck, Elanco, Virbac, Dechra Veterinary Products, Ceva, Vetoquinol and Ouro Fino Saude, etc.



By Company


Zoetis
Boehringer Ingelheim
Merck
Elanco
Virbac
Dechra Veterinary Products
Ceva
Vetoquinol
Ouro Fino Saude
Norbrook
Jindun
Chopperlvya Animal Health
CAHIC
Segment by Type
Antiparasitic
Biological Products
Antibacterial
Others

Segment by Application


Prevention
Treatment
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline


Chapter 1Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2Revenue of Pet Biopharmaceuticals in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3Detailed analysis of Pet Biopharmaceuticals companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6North America by type, by application and by country, revenue for each segment.
Chapter 7Europe by type, by application and by country, revenue for each segment.
Chapter 8China by type and by application revenue for each segment.
Chapter 9Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Pet Biopharmaceuticals revenue, gross margin, and recent development, etc.
Chapter 12Analyst's Viewpoints/Conclusions

Table of Content

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Type, 2018 VS 2022 VS 2034
1.2.2 Antiparasitic
1.2.3 Biological Products
1.2.4 Antibacterial
1.2.5 Others
1.3 Market by Application
1.3.1 Global Pet Biopharmaceuticals Market Size Growth Rate by Application, 2018 VS 2022 VS 2034
1.3.2 Prevention
1.3.3 Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pet Biopharmaceuticals Market Perspective (2018-2034)
2.2 Global Pet Biopharmaceuticals Growth Trends by Region
2.2.1 Pet Biopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2034
2.2.2 Pet Biopharmaceuticals Historic Market Size by Region (2018-2024)
2.2.3 Pet Biopharmaceuticals Forecasted Market Size by Region (2024-2034)
2.3 Pet Biopharmaceuticals Market Dynamics
2.3.1 Pet Biopharmaceuticals Industry Trends
2.3.2 Pet Biopharmaceuticals Market Drivers
2.3.3 Pet Biopharmaceuticals Market Challenges
2.3.4 Pet Biopharmaceuticals Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Pet Biopharmaceuticals by Players
3.1.1 Global Pet Biopharmaceuticals Revenue by Players (2018-2024)
3.1.2 Global Pet Biopharmaceuticals Revenue Market Share by Players (2018-2024)
3.2 Global Pet Biopharmaceuticals Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Pet Biopharmaceuticals, Ranking by Revenue, 2021 VS 2022 VS 2024
3.4 Global Pet Biopharmaceuticals Market Concentration Ratio
3.4.1 Global Pet Biopharmaceuticals Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pet Biopharmaceuticals Revenue in 2022
3.5 Global Key Players of Pet Biopharmaceuticals Head office and Area Served
3.6 Global Key Players of Pet Biopharmaceuticals, Product and Application
3.7 Global Key Players of Pet Biopharmaceuticals, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pet Biopharmaceuticals Breakdown Data by Type
4.1 Global Pet Biopharmaceuticals Historic Market Size by Type (2018-2024)
4.2 Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2034)
5 Pet Biopharmaceuticals Breakdown Data by Application
5.1 Global Pet Biopharmaceuticals Historic Market Size by Application (2018-2024)
5.2 Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2034)
6 North America
6.1 North America Pet Biopharmaceuticals Market Size (2018-2034)
6.2 North America Pet Biopharmaceuticals Market Size by Type
6.2.1 North America Pet Biopharmaceuticals Market Size by Type (2018-2024)
6.2.2 North America Pet Biopharmaceuticals Market Size by Type (2024-2034)
6.2.3 North America Pet Biopharmaceuticals Market Share by Type (2018-2034)
6.3 North America Pet Biopharmaceuticals Market Size by Application
6.3.1 North America Pet Biopharmaceuticals Market Size by Application (2018-2024)
6.3.2 North America Pet Biopharmaceuticals Market Size by Application (2024-2034)
6.3.3 North America Pet Biopharmaceuticals Market Share by Application (2018-2034)
6.4 North America Pet Biopharmaceuticals Market Size by Country
6.4.1 North America Pet Biopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2034
6.4.2 North America Pet Biopharmaceuticals Market Size by Country (2018-2024)
6.4.3 North America Pet Biopharmaceuticals Market Size by Country (2024-2034)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Pet Biopharmaceuticals Market Size (2018-2034)
7.2 Europe Pet Biopharmaceuticals Market Size by Type
7.2.1 Europe Pet Biopharmaceuticals Market Size by Type (2018-2024)
7.2.2 Europe Pet Biopharmaceuticals Market Size by Type (2024-2034)
7.2.3 Europe Pet Biopharmaceuticals Market Share by Type (2018-2034)
7.3 Europe Pet Biopharmaceuticals Market Size by Application
7.3.1 Europe Pet Biopharmaceuticals Market Size by Application (2018-2024)
7.3.2 Europe Pet Biopharmaceuticals Market Size by Application (2024-2034)
7.3.3 Europe Pet Biopharmaceuticals Market Share by Application (2018-2034)
7.4 Europe Pet Biopharmaceuticals Market Size by Country
7.4.1 Europe Pet Biopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2034
7.4.2 Europe Pet Biopharmaceuticals Market Size by Country (2018-2024)
7.4.3 Europe Pet Biopharmaceuticals Market Size by Country (2024-2034)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Pet Biopharmaceuticals Market Size (2018-2034)
8.2 China Pet Biopharmaceuticals Market Size by Type
8.2.1 China Pet Biopharmaceuticals Market Size by Type (2018-2024)
8.2.2 China Pet Biopharmaceuticals Market Size by Type (2024-2034)
8.2.3 China Pet Biopharmaceuticals Market Share by Type (2018-2034)
8.3 China Pet Biopharmaceuticals Market Size by Application
8.3.1 China Pet Biopharmaceuticals Market Size by Application (2018-2024)
8.3.2 China Pet Biopharmaceuticals Market Size by Application (2024-2034)
8.3.3 China Pet Biopharmaceuticals Market Share by Application (2018-2034)
9 Asia (excluding China)
9.1 Asia Pet Biopharmaceuticals Market Size (2018-2034)
9.2 Asia Pet Biopharmaceuticals Market Size by Type
9.2.1 Asia Pet Biopharmaceuticals Market Size by Type (2018-2024)
9.2.2 Asia Pet Biopharmaceuticals Market Size by Type (2024-2034)
9.2.3 Asia Pet Biopharmaceuticals Market Share by Type (2018-2034)
9.3 Asia Pet Biopharmaceuticals Market Size by Application
9.3.1 Asia Pet Biopharmaceuticals Market Size by Application (2018-2024)
9.3.2 Asia Pet Biopharmaceuticals Market Size by Application (2024-2034)
9.3.3 Asia Pet Biopharmaceuticals Market Share by Application (2018-2034)
9.4 Asia Pet Biopharmaceuticals Market Size by Region
9.4.1 Asia Pet Biopharmaceuticals Market Size by Region: 2018 VS 2022 VS 2034
9.4.2 Asia Pet Biopharmaceuticals Market Size by Region (2018-2024)
9.4.3 Asia Pet Biopharmaceuticals Market Size by Region (2024-2034)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size (2018-2034)
10.2 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Type
10.2.1 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Type (2018-2024)
10.2.2 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Type (2024-2034)
10.2.3 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Share by Type (2018-2034)
10.3 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Application
10.3.1 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Application (2018-2024)
10.3.2 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Application (2024-2034)
10.3.3 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Share by Application (2018-2034)
10.4 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country
10.4.1 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country: 2018 VS 2022 VS 2034
10.4.2 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country (2018-2024)
10.4.3 Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country (2024-2034)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Zoetis
11.1.1 Zoetis Company Details
11.1.2 Zoetis Business Overview
11.1.3 Zoetis Pet Biopharmaceuticals Introduction
11.1.4 Zoetis Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.1.5 Zoetis Recent Developments
11.2 Boehringer Ingelheim
11.2.1 Boehringer Ingelheim Company Details
11.2.2 Boehringer Ingelheim Business Overview
11.2.3 Boehringer Ingelheim Pet Biopharmaceuticals Introduction
11.2.4 Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.2.5 Boehringer Ingelheim Recent Developments
11.3 Merck
11.3.1 Merck Company Details
11.3.2 Merck Business Overview
11.3.3 Merck Pet Biopharmaceuticals Introduction
11.3.4 Merck Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.3.5 Merck Recent Developments
11.4 Elanco
11.4.1 Elanco Company Details
11.4.2 Elanco Business Overview
11.4.3 Elanco Pet Biopharmaceuticals Introduction
11.4.4 Elanco Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.4.5 Elanco Recent Developments
11.5 Virbac
11.5.1 Virbac Company Details
11.5.2 Virbac Business Overview
11.5.3 Virbac Pet Biopharmaceuticals Introduction
11.5.4 Virbac Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.5.5 Virbac Recent Developments
11.6 Dechra Veterinary Products
11.6.1 Dechra Veterinary Products Company Details
11.6.2 Dechra Veterinary Products Business Overview
11.6.3 Dechra Veterinary Products Pet Biopharmaceuticals Introduction
11.6.4 Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.6.5 Dechra Veterinary Products Recent Developments
11.7 Ceva
11.7.1 Ceva Company Details
11.7.2 Ceva Business Overview
11.7.3 Ceva Pet Biopharmaceuticals Introduction
11.7.4 Ceva Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.7.5 Ceva Recent Developments
11.8 Vetoquinol
11.8.1 Vetoquinol Company Details
11.8.2 Vetoquinol Business Overview
11.8.3 Vetoquinol Pet Biopharmaceuticals Introduction
11.8.4 Vetoquinol Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.8.5 Vetoquinol Recent Developments
11.9 Ouro Fino Saude
11.9.1 Ouro Fino Saude Company Details
11.9.2 Ouro Fino Saude Business Overview
11.9.3 Ouro Fino Saude Pet Biopharmaceuticals Introduction
11.9.4 Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.9.5 Ouro Fino Saude Recent Developments
11.10 Norbrook
11.10.1 Norbrook Company Details
11.10.2 Norbrook Business Overview
11.10.3 Norbrook Pet Biopharmaceuticals Introduction
11.10.4 Norbrook Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.10.5 Norbrook Recent Developments
11.11 Jindun
11.11.1 Jindun Company Details
11.11.2 Jindun Business Overview
11.11.3 Jindun Pet Biopharmaceuticals Introduction
11.11.4 Jindun Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.11.5 Jindun Recent Developments
11.12 Chopperlvya Animal Health
11.12.1 Chopperlvya Animal Health Company Details
11.12.2 Chopperlvya Animal Health Business Overview
11.12.3 Chopperlvya Animal Health Pet Biopharmaceuticals Introduction
11.12.4 Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.12.5 Chopperlvya Animal Health Recent Developments
11.13 CAHIC
11.13.1 CAHIC Company Details
11.13.2 CAHIC Business Overview
11.13.3 CAHIC Pet Biopharmaceuticals Introduction
11.13.4 CAHIC Revenue in Pet Biopharmaceuticals Business (2018-2024)
11.13.5 CAHIC Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Figure

List of Tables
Table 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2034
Table 2. Key Players of Antiparasitic
Table 3. Key Players of Biological Products
Table 4. Key Players of Antibacterial
Table 5. Key Players of Others
Table 6. Global Pet Biopharmaceuticals Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2034
Table 7. Global Pet Biopharmaceuticals Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 8. Global Pet Biopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 9. Global Pet Biopharmaceuticals Market Share by Region (2018-2024)
Table 10. Global Pet Biopharmaceuticals Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 11. Global Pet Biopharmaceuticals Market Share by Region (2024-2034)
Table 12. Pet Biopharmaceuticals Market Trends
Table 13. Pet Biopharmaceuticals Market Drivers
Table 14. Pet Biopharmaceuticals Market Challenges
Table 15. Pet Biopharmaceuticals Market Restraints
Table 16. Global Pet Biopharmaceuticals Revenue by Players (2018-2024) & (US$ Million)
Table 17. Global Pet Biopharmaceuticals Revenue Share by Players (2018-2024)
Table 18. Global Top Pet Biopharmaceuticals by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)
Table 19. Global Pet Biopharmaceuticals Industry Ranking 2021 VS 2022 VS 2024
Table 20. Global 5 Largest Players Market Share by Pet Biopharmaceuticals Revenue (CR5 and HHI) & (2018-2024)
Table 21. Global Key Players of Pet Biopharmaceuticals, Headquarters and Area Served
Table 22. Global Key Players of Pet Biopharmaceuticals, Product and Application
Table 23. Global Key Players of Pet Biopharmaceuticals, Product and Application
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 26. Global Pet Biopharmaceuticals Revenue Market Share by Type (2018-2024)
Table 27. Global Pet Biopharmaceuticals Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 28. Global Pet Biopharmaceuticals Revenue Market Share by Type (2024-2034)
Table 29. Global Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 30. Global Pet Biopharmaceuticals Revenue Share by Application (2018-2024)
Table 31. Global Pet Biopharmaceuticals Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 32. Global Pet Biopharmaceuticals Revenue Share by Application (2024-2034)
Table 33. North America Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 34. North America Pet Biopharmaceuticals Market Size by Type (2024-2034) & (US$ Million)
Table 35. North America Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 36. North America Pet Biopharmaceuticals Market Size by Application (2024-2034) & (US$ Million)
Table 37. North America Pet Biopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 38. North America Pet Biopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 39. North America Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 40. Europe Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 41. Europe Pet Biopharmaceuticals Market Size by Type (2024-2034) & (US$ Million)
Table 42. Europe Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 43. Europe Pet Biopharmaceuticals Market Size by Application (2024-2034) & (US$ Million)
Table 44. Europe Pet Biopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 45. Europe Pet Biopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 46. Europe Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 47. China Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 48. China Pet Biopharmaceuticals Market Size by Type (2024-2034) & (US$ Million)
Table 49. China Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 50. China Pet Biopharmaceuticals Market Size by Application (2024-2034) & (US$ Million)
Table 51. Asia Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 52. Asia Pet Biopharmaceuticals Market Size by Type (2024-2034) & (US$ Million)
Table 53. Asia Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 54. Asia Pet Biopharmaceuticals Market Size by Application (2024-2034) & (US$ Million)
Table 55. Asia Pet Biopharmaceuticals Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2034
Table 56. Asia Pet Biopharmaceuticals Market Size by Region (2018-2024) & (US$ Million)
Table 57. Asia Pet Biopharmaceuticals Market Size by Region (2024-2034) & (US$ Million)
Table 58. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Type (2018-2024) & (US$ Million)
Table 59. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Type (2024-2034) & (US$ Million)
Table 60. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Application (2018-2024) & (US$ Million)
Table 61. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Application (2024-2034) & (US$ Million)
Table 62. Middle East, Africa, and Latin America Pet Biopharmaceuticals Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2034
Table 63. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country (2018-2024) & (US$ Million)
Table 64. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size by Country (2024-2034) & (US$ Million)
Table 65. Zoetis Company Details
Table 66. Zoetis Business Overview
Table 67. Zoetis Pet Biopharmaceuticals Product
Table 68. Zoetis Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 69. Zoetis Recent Developments
Table 70. Boehringer Ingelheim Company Details
Table 71. Boehringer Ingelheim Business Overview
Table 72. Boehringer Ingelheim Pet Biopharmaceuticals Product
Table 73. Boehringer Ingelheim Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 74. Boehringer Ingelheim Recent Developments
Table 75. Merck Company Details
Table 76. Merck Business Overview
Table 77. Merck Pet Biopharmaceuticals Product
Table 78. Merck Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 79. Merck Recent Developments
Table 80. Elanco Company Details
Table 81. Elanco Business Overview
Table 82. Elanco Pet Biopharmaceuticals Product
Table 83. Elanco Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 84. Elanco Recent Developments
Table 85. Virbac Company Details
Table 86. Virbac Business Overview
Table 87. Virbac Pet Biopharmaceuticals Product
Table 88. Virbac Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 89. Virbac Recent Developments
Table 90. Dechra Veterinary Products Company Details
Table 91. Dechra Veterinary Products Business Overview
Table 92. Dechra Veterinary Products Pet Biopharmaceuticals Product
Table 93. Dechra Veterinary Products Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 94. Dechra Veterinary Products Recent Developments
Table 95. Ceva Company Details
Table 96. Ceva Business Overview
Table 97. Ceva Pet Biopharmaceuticals Product
Table 98. Ceva Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 99. Ceva Recent Developments
Table 100. Vetoquinol Company Details
Table 101. Vetoquinol Business Overview
Table 102. Vetoquinol Pet Biopharmaceuticals Product
Table 103. Vetoquinol Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 104. Vetoquinol Recent Developments
Table 105. Ouro Fino Saude Company Details
Table 106. Ouro Fino Saude Business Overview
Table 107. Ouro Fino Saude Pet Biopharmaceuticals Product
Table 108. Ouro Fino Saude Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 109. Ouro Fino Saude Recent Developments
Table 110. Norbrook Company Details
Table 111. Norbrook Business Overview
Table 112. Norbrook Pet Biopharmaceuticals Product
Table 113. Norbrook Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 114. Norbrook Recent Developments
Table 115. Jindun Company Details
Table 116. Jindun Business Overview
Table 117. Jindun Pet Biopharmaceuticals Product
Table 118. Jindun Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 119. Jindun Recent Developments
Table 120. Chopperlvya Animal Health Company Details
Table 121. Chopperlvya Animal Health Business Overview
Table 122. Chopperlvya Animal Health Pet Biopharmaceuticals Product
Table 123. Chopperlvya Animal Health Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 124. Chopperlvya Animal Health Recent Developments
Table 125. CAHIC Company Details
Table 126. CAHIC Business Overview
Table 127. CAHIC Pet Biopharmaceuticals Product
Table 128. CAHIC Revenue in Pet Biopharmaceuticals Business (2018-2024) & (US$ Million)
Table 129. CAHIC Recent Developments
Table 130. Research Programs/Design for This Report
Table 131. Key Data Information from Secondary Sources
Table 132. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Pet Biopharmaceuticals Market Size Growth Rate by Type, 2018 VS 2022 VS 2034 (US$ Million)
Figure 2. Global Pet Biopharmaceuticals Market Share by Type: 2022 VS 2034
Figure 3. Antiparasitic Features
Figure 4. Biological Products Features
Figure 5. Antibacterial Features
Figure 6. Others Features
Figure 7. Global Pet Biopharmaceuticals Market Size Growth Rate by Application, 2018 VS 2022 VS 2034 (US$ Million)
Figure 8. Global Pet Biopharmaceuticals Market Share by Application: 2022 VS 2034
Figure 9. Prevention Case Studies
Figure 10. Treatment Case Studies
Figure 11. Pet Biopharmaceuticals Report Years Considered
Figure 12. Global Pet Biopharmaceuticals Market Size (US$ Million), Year-over-Year: 2018-2034
Figure 13. Global Pet Biopharmaceuticals Market Size, (US$ Million), 2018 VS 2022 VS 2034
Figure 14. Global Pet Biopharmaceuticals Market Share by Region: 2022 VS 2034
Figure 15. Global Pet Biopharmaceuticals Market Share by Players in 2022
Figure 16. Global Top Pet Biopharmaceuticals Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pet Biopharmaceuticals as of 2022)
Figure 17. The Top 10 and 5 Players Market Share by Pet Biopharmaceuticals Revenue in 2022
Figure 18. North America Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 19. North America Pet Biopharmaceuticals Market Share by Type (2018-2034)
Figure 20. North America Pet Biopharmaceuticals Market Share by Application (2018-2034)
Figure 21. North America Pet Biopharmaceuticals Market Share by Country (2018-2034)
Figure 22. United States Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 23. Canada Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 24. Europe Pet Biopharmaceuticals Market Size YoY (2018-2034) & (US$ Million)
Figure 25. Europe Pet Biopharmaceuticals Market Share by Type (2018-2034)
Figure 26. Europe Pet Biopharmaceuticals Market Share by Application (2018-2034)
Figure 27. Europe Pet Biopharmaceuticals Market Share by Country (2018-2034)
Figure 28. Germany Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 29. France Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 30. U.K. Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 31. Italy Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 32. Russia Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 33. Nordic Countries Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 34. China Pet Biopharmaceuticals Market Size YoY (2018-2034) & (US$ Million)
Figure 35. China Pet Biopharmaceuticals Market Share by Type (2018-2034)
Figure 36. China Pet Biopharmaceuticals Market Share by Application (2018-2034)
Figure 37. Asia Pet Biopharmaceuticals Market Size YoY (2018-2034) & (US$ Million)
Figure 38. Asia Pet Biopharmaceuticals Market Share by Type (2018-2034)
Figure 39. Asia Pet Biopharmaceuticals Market Share by Application (2018-2034)
Figure 40. Asia Pet Biopharmaceuticals Market Share by Region (2018-2034)
Figure 41. Japan Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 42. South Korea Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 43. China Taiwan Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 44. Southeast Asia Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 45. India Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 46. Australia Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 47. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Size YoY (2018-2034) & (US$ Million)
Figure 48. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Share by Type (2018-2034)
Figure 49. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Share by Application (2018-2034)
Figure 50. Middle East, Africa, and Latin America Pet Biopharmaceuticals Market Share by Country (2018-2034)
Figure 51. Brazil Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 52. Mexico Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 53. Turkey Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 54. Saudi Arabia Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 55. Israel Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 56. GCC Countries Pet Biopharmaceuticals Market Size YoY Growth (2018-2034) & (US$ Million)
Figure 57. Zoetis Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 58. Boehringer Ingelheim Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 59. Merck Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 60. Elanco Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 61. Virbac Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 62. Dechra Veterinary Products Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 63. Ceva Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 64. Vetoquinol Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 65. Ouro Fino Saude Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 66. Norbrook Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 67. Jindun Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 68. Chopperlvya Animal Health Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 69. CAHIC Revenue Growth Rate in Pet Biopharmaceuticals Business (2018-2024)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed